Article
Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C
Registro en:
SENFF, Tina et al. Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C. JCIinsight, v. 7, n. 2, e155432, p. 1 - 15, Jan. 2022.
2379-3708
10.1172/jci. insight.155432.
Autor
Senff, Tina
Menne, Christopher
Cosmovici, Christine
Lewis-Ximenez, Lia Laura
Aneja, Jasneet
Broering, Ruth
Kim, Arthur Y.
Westendorf, Astrid M.
Dittmer, Ulf
Scherbaum, Norbert
Lauer, Georg M.
Timm, Jörg
Resumen
Invariant NK T (iNKT) cells are implicated in viral clearance; however, their role in hepatitis C virus
(HCV) infection remains controversial. Here, iNKT cells were studied during different stages of HCV
infection. iNKT cells from patients with acute HCV infection and people who inject drugs (PWID)
with chronic or spontaneously resolved HCV infection were characterized by flow cytometry. In
a longitudinal analysis during acute HCV infection, frequencies of activated CD38+ iNKT cells
reproducibly declined in spontaneously resolving patients, whereas they were persistently elevated
in patients progressing to chronic infection. During the first year of infection, the frequency of
activated CD38+ or CD69+ iNKT cells strongly correlated with alanine transaminase levels with
particularly pronounced correlations in spontaneously resolving patients. Increased frequencies of
activated iNKT cells in chronic HCV infection were confirmed in cross-sectional analyses of PWID
with chronic or spontaneously resolved HCV infection; however, no apparent functional differences
were observed with various stimulation protocols. Our data suggest that iNKT cells are activated
during acute hepatitis C and that activation is sustained in chronic infection. The correlation
between the frequency of activated iNKT cells and alanine transaminase may point toward a role of
iNKT cells in liver damage.